Lataa...
Oromucosal immunomodulation as clinical spectrum mitigating factor in SARS‐CoV‐2 infection
Mounting evidence supports the importance of mucosal immunity in the immune response to SARS‐CoV‐2. Active virus replication in the upper respiratory tract for the first days of infection opens a new perspective in immunological strategies to counteract viral pathogenicity. An effective mucosal inna...
Tallennettuna:
| Julkaisussa: | Scand J Immunol |
|---|---|
| Päätekijät: | , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
John Wiley and Sons Inc.
2020
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7816245/ https://ncbi.nlm.nih.gov/pubmed/32892403 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/sji.12972 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|